TEH SENG PHARMACEUTICAL MANUFACTURING
TEH SENG PHARMACEUTICAL MANUFACTURING, commonly referred to as Teh Seng, is a prominent player in the pharmaceutical industry, headquartered in Taiwan (TW). Established in 1975, the company has built a strong reputation for its commitment to quality and innovation in the production of pharmaceutical products, including generic medications and active pharmaceutical ingredients (APIs). With a robust operational presence across Asia, Teh Seng has achieved significant milestones, including certifications from various international regulatory bodies. The company is renowned for its state-of-the-art manufacturing processes and adherence to stringent quality standards, setting it apart in a competitive market. Teh Seng's dedication to research and development has positioned it as a trusted partner for healthcare providers, contributing to its notable achievements in the pharmaceutical sector.
DitchCarbon Score
How does TEH SENG PHARMACEUTICAL MANUFACTURING's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TEH SENG PHARMACEUTICAL MANUFACTURING's score of 0 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TEH SENG PHARMACEUTICAL MANUFACTURING's reported carbon emissions
TEH SENG PHARMACEUTICAL MANUFACTURING, headquartered in Taiwan (TW), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the pharmaceutical manufacturing industry, companies are increasingly recognising the importance of addressing carbon emissions and setting reduction targets to align with global climate goals. As such, TEH SENG PHARMACEUTICAL MANUFACTURING may benefit from developing a comprehensive strategy to measure and reduce its carbon footprint in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TEH SENG PHARMACEUTICAL MANUFACTURING is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
